CV risk profile subgroups To assess the effect of baseline CV risk profiles on outcomes, two separate subgroup analyses were performed: (1) for subjects who had experienced a prior MI or stroke compared with those who had not, and (2) for those with established CVD, defined as prior stroke, ischemic heart disease (including MI), peripheral arterial disease, 50% arterial stenosis in any artery, coronary revascularization (percutaneous coronary intervention or coronary artery bypass graft), or heart failure vs those with CV risk factors alone and no manifestations of CVD as defined above
164,165 Gamma oryzanol has abundant biological activities, including antioxidant 165,166 and anti-inflammatory
Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update
The current NDC structure creates avoidable variation
Anyway keep up the excellent quality writing, it is rare to see a great blog like this one today
It could help understand some of the long-term challenges associated with these treatments